Insider Buy/Sell Details for the Shell Companies Industry — Last 3 Months
Ratio0.3:1
Daily Buy & Sell Volume
Transactions (333)
Redwire Corp (RDW)
AE RED HOLDINGS, LLC — Director
Shares
11,615
Price
$10.01
Total Value
$116.27K
Shares Held After
44,837,719
% of Holdings
0.0%
Oncology Institute, Inc. (TOI)
Chernett Jorey — 10% Owner
Shares
263,000
Price
$2.92
Total Value
$767.96K
Shares Held After
10,115,944
% of Holdings
2.6%
Tevogen Bio Holdings Inc. (TVGN)
Flomenberg Neal — Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026.
Shares
501
Price
$6.40
Total Value
$3.21K
Shares Held After
76,940
% of Holdings
0.6%
Oklo Inc. (OKLO)
Cochran Caroline — Director
Shares
72,960
Price
$60.00
Total Value
$4.38M
Shares Held After
751,533
% of Holdings
8.8%
Oklo Inc. (OKLO)
Cochran Caroline — Director
Shares
44,828
Price
$60.00
Total Value
$2.69M
Shares Held After
718,039
% of Holdings
5.9%
Oklo Inc. (OKLO)
DeWitte Jacob — Director
Shares
44,828
Price
$60.00
Total Value
$2.69M
Shares Held After
718,039
% of Holdings
5.9%
Oklo Inc. (OKLO)
DeWitte Jacob — Director
Shares
72,960
Price
$60.00
Total Value
$4.38M
Shares Held After
751,533
% of Holdings
8.8%
Oklo Inc. (OKLO)
Bealmear Richard Craig — Chief Financial Officer
Shares
72,090
Price
$60.00
Total Value
$4.33M
Shares Held After
386,008
% of Holdings
15.7%
Better Home & Finance Holding Co (BETR)
Framework Ventures IV L.P. — 10% Owner
Shares
29,494
Price
$34.12
Total Value
$1.01M
Shares Held After
834,312
% of Holdings
3.5%
TriSalus Life Sciences, Inc. (TLSI)
Cox Bryan F. — Chief of Research
Shares
1,467
Price
$4.09
Total Value
$6.00K
Shares Held After
163,994
% of Holdings
0.9%
TriSalus Life Sciences, Inc. (TLSI)
Devlin Jodi — Chief of Clinical Operations
Shares
1,772
Price
$4.09
Total Value
$7.25K
Shares Held After
97,637
% of Holdings
1.8%
TriSalus Life Sciences, Inc. (TLSI)
Marshak Richard — Chief Commercial Officer
Shares
1,589
Price
$4.09
Total Value
$6.50K
Shares Held After
110,816
% of Holdings
1.4%
TriSalus Life Sciences, Inc. (TLSI)
Stevens Jennifer — Chief Regulatory Officer
Shares
1,552
Price
$4.09
Total Value
$6.35K
Shares Held After
124,884
% of Holdings
1.2%
OppFi Inc. (OPFI)
Moore Jocelyn — Director
Shares
8,190
Price
$8.53
Total Value
$69.86K
Shares Held After
39,076
% of Holdings
17.3%
IonQ, Inc. (IONQ)
Raymond John w — Director
Shares
2,800
Price
$33.34
Total Value
$93.35K
Shares Held After
83,963
% of Holdings
3.2%
Hagerty, Inc. (HGTY)
Kuczinski Anthony J — Director
Shares
4,000
Price
$9.50
Total Value
$38.00K
Shares Held After
47,277
% of Holdings
8.5%
SmartRent, Inc. (SMRT)
Bohjalian Thomas N — Director
Shares
150,000
Price
$1.74
Total Value
$260.49K
Shares Held After
500,000
% of Holdings
30.0%
TriSalus Life Sciences, Inc. (TLSI)
Cox Bryan F. — Chief of Research
Shares
1,138
Price
$4.13
Total Value
$4.70K
Shares Held After
165,461
% of Holdings
0.7%
TriSalus Life Sciences, Inc. (TLSI)
Devlin Jodi — Chief of Clinical Operations
Shares
1,162
Price
$4.13
Total Value
$4.80K
Shares Held After
99,409
% of Holdings
1.2%
TriSalus Life Sciences, Inc. (TLSI)
Szela Mary T — Director
Shares
4,358
Price
$4.13
Total Value
$18.00K
Shares Held After
768,931
% of Holdings
0.6%
TriSalus Life Sciences, Inc. (TLSI)
Marshak Richard — Chief Commercial Officer
Shares
1,449
Price
$4.13
Total Value
$5.98K
Shares Held After
112,405
% of Holdings
1.3%
TriSalus Life Sciences, Inc. (TLSI)
Stevens Jennifer — Chief Regulatory Officer
Shares
1,204
Price
$4.13
Total Value
$4.97K
Shares Held After
126,436
% of Holdings
0.9%
Tevogen Bio Holdings Inc. (TVGN)
Flomenberg Neal — Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026.
Shares
452
Price
$7.26
Total Value
$3.28K
Shares Held After
77,441
% of Holdings
0.6%
Better Home & Finance Holding Co (BETR)
Framework Ventures IV L.P. — 10% Owner
Shares
21,598
Price
$39.73
Total Value
$858.09K
Shares Held After
804,818
% of Holdings
2.7%
Tevogen Bio Holdings Inc. (TVGN)
Flomenberg Neal — Chief Scientific Officer, Global R&D Lead.
All holdings herein have been adjusted to reflect the Company's 1-for-50 reverse stock split effected on March 6, 2026.
Shares
19
Price
$7.75
Total Value
$147.25
Shares Held After
77,893
% of Holdings
0.0%
FLYEXCLUSIVE INC. (FLYX)
Hopper Peter B. — Director
Shares
50,000
Price
$2.38
Total Value
$119.23K
Shares Held After
100,000
% of Holdings
50.0%
GeneDx Holdings Corp. (WGS)
Feeley Kevin — CHIEF FINANCIAL OFFICER
Shares
1,280
Price
$86.75
Total Value
$111.05K
Shares Held After
21,842
% of Holdings
5.5%
Better Home & Finance Holding Co (BETR)
Framework Ventures IV L.P. — 10% Owner
Shares
10,000
Price
$35.46
Total Value
$354.60K
Shares Held After
571,908
% of Holdings
1.7%
GeneDx Holdings Corp. (WGS)
Stueland Katherine — Director
Shares
3,678
Price
$86.75
Total Value
$319.06K
Shares Held After
44,955
% of Holdings
7.6%
Oklo Inc. (OKLO)
Goodwin William Carroll Murphy — Chief Legal & Strategy Officer
Shares
2,820
Price
$56.69
Total Value
$159.87K
Shares Held After
15,991
% of Holdings
15.0%
FLYEXCLUSIVE INC. (FLYX)
Hopper Peter B. — Director
Shares
50,000
Price
$2.54
Total Value
$127.12K
Shares Held After
50,000
% of Holdings
100.0%
SBC Medical Group Holdings Inc (SBC)
Aikawa Yoshiyuki — Director
Shares
4,422,900
Price
$2.12
Total Value
$9.38M
Shares Held After
861,600
% of Holdings
83.7%
Tango Therapeutics, Inc. (TNGX)
Crystal Adam — President, R&D
Shares
20,251
Price
$15.00
Total Value
$303.76K
Shares Held After
112,622
% of Holdings
15.2%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
29,236
Price
$82.06
Total Value
$2.40M
Shares Held After
3,228,150
% of Holdings
0.9%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
60,892
Price
$81.37
Total Value
$4.95M
Shares Held After
3,198,914
% of Holdings
1.9%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
47,623
Price
$80.55
Total Value
$3.84M
Shares Held After
3,138,022
% of Holdings
1.5%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
1,971
Price
$78.91
Total Value
$155.53K
Shares Held After
3,090,399
% of Holdings
0.1%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
304
Price
$77.96
Total Value
$23.70K
Shares Held After
3,088,428
% of Holdings
0.0%
GeneDx Holdings Corp. (WGS)
Feeley Kevin — CHIEF FINANCIAL OFFICER
Shares
2,220
Price
$79.25
Total Value
$175.93K
Shares Held After
18,674
% of Holdings
10.6%
GeneDx Holdings Corp. (WGS)
Feeley Kevin — CHIEF FINANCIAL OFFICER
Shares
2,543
Price
$78.61
Total Value
$199.90K
Shares Held After
20,894
% of Holdings
10.9%
GeneDx Holdings Corp. (WGS)
Feeley Kevin — CHIEF FINANCIAL OFFICER
Shares
1,424
Price
$77.63
Total Value
$110.54K
Shares Held After
23,437
% of Holdings
5.7%
GeneDx Holdings Corp. (WGS)
Stueland Katherine — Director
Shares
9,133
Price
$79.25
Total Value
$723.78K
Shares Held After
38,683
% of Holdings
19.1%
GeneDx Holdings Corp. (WGS)
Stueland Katherine — Director
Shares
10,465
Price
$78.61
Total Value
$822.62K
Shares Held After
47,816
% of Holdings
18.0%
GeneDx Holdings Corp. (WGS)
Stueland Katherine — Director
Shares
5,861
Price
$77.63
Total Value
$454.97K
Shares Held After
58,281
% of Holdings
9.1%
Global Business Travel Group, Inc. (GBTG)
Thompson John David — Chief Technology Officer
Shares
109,020
Price
$5.74
Total Value
$625.77K
Shares Held After
735,701
% of Holdings
12.9%
Hagerty, Inc. (HGTY)
Kuczinski Anthony J — Director
Shares
15,000
Price
$10.72
Total Value
$160.80K
Shares Held After
43,277
% of Holdings
34.7%
Oklo Inc. (OKLO)
Bealmear Richard Craig — Chief Financial Officer
Shares
5,839
Price
$61.93
Total Value
$361.61K
Shares Held After
294,255
% of Holdings
1.9%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
249
Price
$75.99
Total Value
$18.92K
Shares Held After
3,088,124
% of Holdings
0.0%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
921
Price
$75.66
Total Value
$69.68K
Shares Held After
3,087,875
% of Holdings
0.0%
GeneDx Holdings Corp. (WGS)
Meister Keith A. — Director
Shares
200
Price
$72.00
Total Value
$14.40K
Shares Held After
3,086,954
% of Holdings
0.0%
Showing 151–200 of 333 transactions (page 4 of 7)